DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zrbhm8/the_global) has announced the addition of the "The Global Non-Invasive Prenatal Diagnostics Market" report to their offering.
The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used as a non-invasive method for prenatal diagnostics. The report will also provide a market analysis of the market value, growth rates and market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry, and the factors influencing the market shares of the major market suppliers as well as smaller indigenous manufacturers in local markets.
The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models.
The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis.
Key Topics Covered:
- Introduction to the Non-invasive Prenatal Diagnostics Market
- Background to Circulating Nucleic Acids
- Market Revenue Analysis: Non-invasive Prenatal Diagnostics
- Market Share Analysis: Non-invasive Prenatal Diagnostics
- Company Profiles
Chapter 1: Introduction to the Non- invasive Prenatal Diagnostics Market
Chapter 2: Background to Circulating Nucleic Acids
- Introduction to Circulating Nucleic Acids (CNAs)
- Categories of Circulating Nucleic Acids
- Circulating Nucleic Acids as a Diagnostic Tool
- Methods Used for the Detection of Circulating Nucleic Acids
Chapter 3: Market Revenue Analysis: Non- invasive Prenatal Diagnostics
- Market Dynamics
- Selected Non-invasive Prenatal Diagnostic Products
- Market Revenue Analysis
Chapter 4: Market Share Analysis: Non- invasive Prenatal Diagnostics
Chapter 5: Company Profiles
- Ariosa Diagnostics
- Sequenom Inc
- Natera Inc
- LifeCodexx AG
- Verinata Health, Inc (Illumina, Inc)
- Illumina, Inc.,
- Berry Genomics Co., Ltd
- BGI Diagnostics (Division of BGI)
For more information visit http://www.researchandmarkets.com/research/zrbhm8/the_global